Cardinal Health (CAH) Liabilities and Shareholders Equity (2009 - 2026)
Cardinal Health's (CAH) quarterly Liabilities and Shareholders Equity came in at $56.7 billion in Q1 2026, up 13.67% year-on-year from $49.9 billion in Q1 2025, and down 2.4% quarter-over-quarter from $58.1 billion in Q4 2025.
Cardinal Health (CAH) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Cardinal Health has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $56.7 billion for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $56.7 billion, up 13.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $223.1 billion (up 20.57% YoY), and the FY2025 annual result was $53.1 billion, up 17.73% from the prior year.
- Liabilities and Shareholders Equity came in at $56.7 billion for Q1 2026 at Cardinal Health, down from $58.1 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $58.1 billion in Q4 2025 to a low of $42.1 billion in Q1 2022.
- The 5-year median for Liabilities and Shareholders Equity is $45.1 billion (2024), against an average of $47.3 billion.
- Across the five-year window, Liabilities and Shareholders Equity slipped 4.02% in 2022 and grew 28.26% in 2025, its largest moves.
- Cardinal Health's Liabilities and Shareholders Equity stood at $44.5 billion in 2022, then gained by 4.7% to $46.6 billion in 2023, then climbed by 0.92% to $47.0 billion in 2024, then increased by 23.58% to $58.1 billion in 2025, then retreated by 2.4% to $56.7 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $56.7 billion (Q1 2026), $58.1 billion (Q4 2025), and $55.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 212.04 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 82.32 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 81.65 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 56.69 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 11.30 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.42 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 72.06 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 310.22 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 62.37 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.69 Bn |
| Dec 31, 2025 | 58.08 Bn |
| Sep 30, 2025 | 55.23 Bn |
| Jun 30, 2025 | 53.12 Bn |
| Mar 31, 2025 | 49.87 Bn |
| Dec 31, 2024 | 47.00 Bn |
| Sep 30, 2024 | 43.06 Bn |
| Jun 30, 2024 | 45.12 Bn |
| Mar 31, 2024 | 45.88 Bn |
| Dec 31, 2023 | 46.57 Bn |
| Sep 30, 2023 | 43.71 Bn |
| Jun 30, 2023 | 43.35 Bn |
| Mar 31, 2023 | 43.38 Bn |
| Dec 31, 2022 | 44.48 Bn |
| Sep 30, 2022 | 43.39 Bn |
| Jun 30, 2022 | 43.88 Bn |
| Mar 31, 2022 | 42.11 Bn |
| Dec 31, 2021 | 43.68 Bn |
| Sep 30, 2021 | 42.99 Bn |
| Jun 30, 2021 | 44.45 Bn |